Recent Development of Rigors during Infusion of Urokinase: Is it Related to an Endotoxin?

McNamara, 1991, Intra-arterial urokinase as initial therapy for acutely ischemic lower limbs, Circulation, 83, I106 Gardiner, 1992, Catheterdirected thrombolysis for the failed lower extremity bypass graft, Semin Vasc Surg, 5, 99 Gardiner, 1990, Thrombolysis for peripheral arterial occlusions, Radiology, 175, 34, 10.1148/radiology.175.1.2107562 Becker, 1983, Local thrombolytic therapy for subclavian and axillary vein thrombosis, Radiology, 149, 419, 10.1148/radiology.149.2.6622685 Belkin, 1986, Intra-arterial fibrinolytic therapy: efficacy of streptokinase versus urokinase, Arch Surg, 121, 769, 10.1001/archsurg.1986.01400070035007 Bell, 1988, Update on urokinase and streptokinase: a comparison of their efficacy and safety, Hosp Formul, 23, 230 van Breda, 1987, Urokinase versus streptokinase in local thrombolysis, Radiology, 165, 109, 10.1148/radiology.165.1.3628756 Young, 1972, An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation, J Clin Invest, 51, 1790, 10.1172/JCI106980 Rosner, 1990, 161 Dixon, 1985 Bookstein, 1989, Pulsed spray pharmaco- mechanical thrombolysis: preliminary clinical results, AJR, 152, 1097, 10.2214/ajr.152.5.1097 Nazari, 1987, Adverse reactions to thrombolytic agents: implications for coronary perfusion following myocardial infarction, J Med Toxicol, 2, 274, 10.1007/BF03259869 Goldhaber, 1988, Randomized control trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism, Lancet, 2, 293, 10.1016/S0140-6736(88)92354-9 Goldhaber, 1992, Recombinant tissue type plasminogen activator versus a normal dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial, J Am Coll Cardiol, 20, 24, 10.1016/0735-1097(92)90132-7 Matsis, 1992, Rigors and bronchospasm with urokinase after streptokinase, Lancet, 340, 1552, 10.1016/0140-6736(92)92808-S Rholl, 1993, Increased reactions to urokinase: experience at a community hospital and results of SCVIR survey (abstr), JVIR, 4, 24 Turner, 1987, Albumin solutions: their production and quality control, J Dev Biol Stand, 67, 119 Ring, 1977, Incidence and severity of anaphylactoid reactions to colloid volume substitutes, Lancet, 1, 466, 10.1016/S0140-6736(77)91953-5 Greisman, 1969, Comparative pyrogenic reactivity of rabbit and man to bacterial endotoxin (34059), Proc Soc Exp Biol Med, 131, 1154, 10.3181/00379727-131-34059 Hochstein, 1983, The processing and collaborative assay of a reference endotoxin, J Biol Stand, 11, 251, 10.1016/S0092-1157(83)80013-4 Dabbah, 1980, Pyrogenicity of E coli 055:B5 endotoxin by the USP rabbit test: a HIMA collaborative study, J Paren Drug Assoc, 34, 212 Sassahara AA. Special considerations in the management of thrombolysis. Presented at New Developments in the Treatment of Thromboembolic Disease: An Update, Naples, Fla, November 6, 1992. Dinarello, 1988, New concepts on the pathogenesis of fever, Rev Infect Dis, 10, 168, 10.1093/clinids/10.1.168 Engelhardt, 1990, Biological response to intravenously administered endotoxin in patients with advanced cancer, J Biol Response Mod, 9, 480 Burks, 1980, Meperidine for the treatment of shaking chills and fever, Arch Intern Med, 140, 483, 10.1001/archinte.1980.00330160043024 Tynes, 1963, Reducing amphotericin B reactions, Am Rev Respir Dis, 87, 264 Presant, 1980, Amphotericin B: new perspectives (editorial), Arch Intern Med, 140, 469, 10.1001/archinte.140.4.469b